Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation

• Main Authors: J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia, C. Zaltman
• Format: Article
• Language: English
• Published: Elsevier 2017-01-01
• Series: Revista de Gastroenterología de México (English Edition)
• Subjects: Ulcerative colitis; Crohn's disease; Diagnosis; Treatment; Inflammatory bowel disease
• Online Access: http://www.sciencedirect.com/science/article/pii/S2255534X1730004X

The incidence and prevalence of inflammatory bowel disease (IBD) has increased in recent years in several Latin American countries. There is a need to raise awareness in gastroenterologists and the population in general, so that early diagnosis and treatment of ulcerative colitis (UC) and Crohn's Disease (CD) can be carried out. It is important for all physicians to have homogeneous criteria regarding the diagnosis and treatment of IBD in Latin America. The Pan American Crohn's and Colitis Organisation (PANCCO) is an organization that aims to include all the countries of the Americas, but it specifically concentrates on Latin America. The present Consensus was divided into two parts for publication: 1) Diagnosis and treatment and 2) Special situations. This is the first Latin American Consensus whose purpose is to promote a perspective adapted to our Latin American countries for the diagnosis, treatment, and monitoring of patients with UC and CD.